Renal involment in patients with Schönlein-Henoch purpura
pdf (Spanish)

Keywords

IgA Vasculitis
Proteinuria
Nephrotic Syndrome
Child

How to Cite

1.
Madruga Zaera Ángela, Caballero Ramos J, Ríos Crooke C, Urbano Ruiz C, Jiménez Domínguez A, Criado Muriel C. Renal involment in patients with Schönlein-Henoch purpura. Bol Pediatr. 2025;65(272):96-98. doi:10.63788/b0bxhn88

Abstract

Introduction and objectives. Nephropathy associated with Schönlein-Henoch purpura (HSP), now known as IgA vasculitis, is a glomerulonephritis that, when it appears, marks the prognosis and treatment of this disease. The aim of this study was to analyse renal involvement in children with a history of HSP followed in the paediatric nephrology department of a tertiary hospital.

Materials and methods. We designed a descriptive, cross-sectional, and retrospective study. The target population consists of children with a history of HSP and renal involvement who have been followed in the pediatric nephrology clinic of a tertiary hospital over the last 15 years. Medical records were reviewed, and a descriptive analysis was conducted using Excel software.

Results. The final sample consisted of 30 children, with a mean age at diagnosis of 7.13 years. 56.7% presented with transient urinary abnormalities (proteinuria and/or hematuria), while 43.3% had persistent abnormalities. Among the latter, 7 had mild involvement and 6 had moderate/severe involvement. Four biopsies were performed on three of the children. Regarding treatment, nephrotic syndrome patients did not respond to corticosteroids; one responded to cyclosporine and another to tacrolimus. The persistent proteinuria, which appeared one year after diagnosis, did not respond to ACE inhibitors or corticosteroids but did respond to cyclosporine.

Conclusions. Close follow-up of patients with HSP is important, as renal involvement, although generally mild, is variable and fluctuating and influences prognosis. We observed 20% moderate/severe renal involvement.

pdf (Spanish)

References

Dedeoglu F, Kim S. IgA vasculitis (Henoch-Schönlein purpura): Clinical manifestations and diagnosis. En: UpToDate, Connor RF (Ed), Wolters Kluwer. (Accedido el 1 de marzo de 2025).

Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, et al. EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis. 2010; 69(5): 798-806. https://doi.org/10.1136/ard.2009.116657

Ozen S, Marks SD, Brogan P, Groot N, de Graeff N, Avcin T, et al. European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative. Rheumatology (Oxford). 2019; 58(9): 1607-16. https://doi.org/10.1093/rheumatology/kez041

Cheung CK, Barratt J. IgA nephropathy: Clinical features and diagnosis. En: UpToDate, Connor RF (Ed), Wolters Kluwer. (Accedido el 12 de abril de 2025).

Working Group of the International IgA Nephropathy Network and the Renal Pathology Society; Cattran DC, Coppo R, Cook HT, Feehally J, Roberts IS, Troyanov S, et al. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int. 2009; 76(5): 534-45. https://doi.org/10.1038/ki.2009.243

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright (c) 2025 Boletín de Pediatría